Zymergen Announces Launch of Initial Public Offering

EMERYVILLE, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced that it has launched the roadshow for the initial public offering (“IPO”) of 13,600,000 shares of its common stock. The initial offering price is expected to be between $28...

Click to view original post